KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insulet (PODD) Cash & Equivalents (2016 - 2026)

Insulet filings provide 16 years of Cash & Equivalents readings, the most recent being $716.1 million for Q4 2025.

  • On a quarterly basis, Cash & Equivalents fell 24.89% to $716.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $716.1 million, a 24.89% decrease, with the full-year FY2025 number at $716.1 million, down 24.89% from a year prior.
  • Cash & Equivalents hit $716.1 million in Q4 2025 for Insulet, down from $757.4 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $1.3 billion in Q1 2025 to a low of $620.7 million in Q1 2023.
  • Median Cash & Equivalents over the past 5 years was $754.3 million (2024), compared with a mean of $805.8 million.
  • Biggest five-year swings in Cash & Equivalents: skyrocketed 307.5% in 2021 and later decreased 24.89% in 2025.
  • Insulet's Cash & Equivalents stood at $791.6 million in 2021, then fell by 14.77% to $674.7 million in 2022, then increased by 4.37% to $704.2 million in 2023, then soared by 35.39% to $953.4 million in 2024, then decreased by 24.89% to $716.1 million in 2025.
  • The last three reported values for Cash & Equivalents were $716.1 million (Q4 2025), $757.4 million (Q3 2025), and $1.1 billion (Q2 2025) per Business Quant data.